Kangmei Pharma reported CNY2.38B in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Akebia Therapeutics USD 18.7M 5.68M Sep/2026
Avita Medical AUD 5.29M 1.64M Jun/2026
Cspc Pharmaceutical CNY 3.09B 219.95M Dec/2025
Genomma Lab Internacional MXN 2.36B 400.63M Sep/2026
Hypermarcas BRL 1.93B 138.92M Jun/2026
Ionis Pharmaceuticals USD 28.58M 22.26M Sep/2026
Jiangsu Hengrui CNY 3.04B 48.87M Sep/2026
Kangmei Pharma CNY 2.38B 73.9M Mar/2026
Moderna USD 313M 33M Sep/2026
Organon & Co USD 1.36B 4M Sep/2026
Revvity USD 388.85M 10.35M Sep/2026
Sh Fosun Pharma CNY 6B 33.45M Sep/2026
Viatris USD 3.83B 104M Sep/2026
Wuxi Apptec CNY 12.59B 1.47B Sep/2026
Xeris Pharmaceuticals USD 76.92M 4M Sep/2026
Zz Pientze Pharmaceu CNY 5.95B 323.56M Jun/2026